Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHA/688139 stock hub

SHA/688139 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/688139is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
9.9B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/688139
In the news

Latest news · SHA/688139

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E31.8
P25 17.1P50 24.2P75 37.8
Trailing P/E45.5
P25 23.5P50 41.3P75 83.2
ROE4.7
P25 -0.9P50 4.1P75 8.8
ROIC4.8
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/688139 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
225
Groups with data
11
Currency
CNY
Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
2,945
Employees Change
138%
Employees Change Percent
4.92
Enterprise value
CNY 8.8B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Medical Devices
Isin
CNE100003P25
Last refreshed
2026-05-10
Market cap
CNY 9.9B
Price
CNY 31.83
Price currency
CNY
Rev Per Employee
778,187.29x
Sector
Healthcare
Sic
3845
Symbol
sha/688139
Website
https://www.haierbiomedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
2.22%
EV Earnings
39.95x
EV/EBIT
53.26x
EV/EBITDA
31.8x
EV/FCF
64.78x
EV/Sales
3.83x
FCF yield
1.37%
Forward P/E
31.83x
P/B ratio
2.11x
P/E ratio
45.46x
P/S ratio
4.33x
PE Ratio10 Y
39.16x
PE Ratio3 Y
32.56x
PE Ratio5 Y
34.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
7.2%
EBITDA Margin
11.82%
FCF margin
5.92%
Gross margin
46.19%
Gross Profit
CNY 1.1B
Gross Profit Growth
-3.8%
Gross Profit Growth Q
-6.93%
Gross Profit Growth3 Y
-9.74%
Gross Profit Growth5 Y
6.29%
Net Income
CNY 219.9M
Net Income Growth
-35.18%
Net Income Growth Q
-27.93%
Net Income Growth3 Y
-29.39%
Net Income Growth5 Y
-21.37%
Pretax Margin
9.77%
Profit Margin
9.6%
Profit Per Employee
CNY 74,680
ROA
1.76
Roa5y
4.42
ROCE
3.45
ROE
4.65
Roe5y
13.14
ROIC
4.83
Roic5y
29.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
0.77%
Cagr3y
-22.23%
Cagr5y
-19.01%
Div CAGR3
-2.05%
EPS Growth
-34.66
EPS Growth Q
-28.57
EPS Growth3 Y
-29.03
EPS Growth5 Y
-20.76
FCF Growth
-1.36%
FCF Growth3 Y
-27.66%
FCF Growth5 Y
-28.15%
OCF Growth
-3.71%
OCF Growth Q
-68.63%
OCF Growth3 Y
-27.69%
OCF Growth5 Y
-20.79%
Revenue Growth
0.26x
Revenue Growth Q
-5.36x
Revenue Growth3 Y
-8.46x
Revenue Growth5 Y
8.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CNY 0.39
Assets
CNY 5.9B
Cash
CNY 1.5B
Current Assets
CNY 2.7B
Current Liabilities
CNY 1.1B
Debt
CNY 95.1M
Debt EBITDA
CNY 0.34
Debt Equity
CNY 0.02
Debt FCF
CNY 0.7
Equity
CNY 4.7B
Interest Coverage
42.2
Liabilities
CNY 1.2B
Long Term Assets
CNY 3.1B
Long Term Liabilities
CNY 85.1M
Net Cash
CNY 1.4B
Net Cash By Market Cap
CNY 13.95
Net Cash Growth
-18.55%
Net Debt EBITDA
CNY -5.11
Net Debt Equity
CNY -0.29
Net Debt FCF
CNY -10.2
Tangible Book Value
CNY 3.3B
Tangible Book Value Per Share
CNY 10.53
WACC
7.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.57
Inventory Turnover
3.85
Net Working Capital
CNY 284.5M
Quick ratio
1.9
Working Capital
CNY 1.7B
Working Capital Turnover
CNY 1.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.79%
Dividend Growth
-8.74%
Dividend Growth Years
0%
Dividend per share
CNY 0.33
Dividend Years
6
Dividend Yield
1.04%
Ex Div Date
2025-06-06
Last Dividend
CNY 0.47
Payout Frequency
Annual
Payout Ratio
67.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
0.77%
200-day SMA
32.88
3Y total return
-52.96%
50-day SMA
32.05
50-day SMA vs 200-day SMA
50under200
5Y total return
-65.14%
All Time High
150.9
All Time High Change
-78.9%
All Time High Date
2021-08-19
All Time Low
23.87
All Time Low Change
33.35%
All Time Low Date
2019-11-12
ATR
0.95
Beta
0.56
Beta1y
0.46
Beta2y
0.7
Ch YTD
0.16
High
32.21
High52
38.8
High52 Date
2026-01-14
High52ch
-17.96%
Low
31.58
Low52
29.68
Low52 Date
2025-06-20
Low52ch
7.24%
Ma50ch
-0.7%
Price vs 200-day SMA
-3.19%
RSI
46.29
RSI Monthly
43.55
RSI Weekly
46.84
Sharpe ratio
-0.09x
Sortino ratio
0.11
Total Return
1.83%
Tr YTD
0.16
Tr1m
3.04%
Tr1w
0.86%
Tr3m
-1.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 165M
Operating Income Growth
-42.84
Operating Income Growth Q
-14.92
Operating Income Growth3 Y
-35.1
Operating Income Growth5 Y
-13.01
Operating margin
7.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
149,172,229%
Net Borrowing
-8,768,341
Shares Insiders
0.06%
Shares Institutions
19.96%
Shares Out
311,713,779
Shares Qo Q
2.88%
Shares Yo Y
-0.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
CNY 135.6M
Average Volume
3,533,950.45x
Bv Per Share
14.01
CAPEX
CNY -106.7M
Ch1m
3.04
Ch1w
0.86
Ch1y
-0.75
Ch3m
-1.79
Ch3y
-54.65
Ch5y
-66.74
Ch6m
-8.11
Change
0.66%
Change From Open
0.6
Close
31.62
Days Gap
0.06
Depreciation Amortization
105,933,921
Dollar Volume
73,553,368.8
Earnings Date
2026-04-30
EBIT
CNY 165M
EBITDA
CNY 270.9M
EPS
CNY 0.7
F Score
4
FCF
CNY 135.6M
FCF EV Yield
1.54x
FCF Per Share
CNY 0.44
Financing CF
-252,201,230
Fiscal Year End
December
Founded
2,005
Goodwill
757,847,032
Graham Number
14.85801
Graham Upside
-53.32
Income Tax
CNY 5M
Investing CF
177,851,013
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Lynch Fair Value
CNY 3.5
Lynch Upside
-89
Ma150
32.77
Ma150ch
-2.87%
Ma20
32.58
Ma20ch
-2.31%
Net CF
162,562,405
Next Earnings Date
2026-08-21
Open
31.64
P FCF Ratio
73.16
P OCF Ratio
40.94
Payment Date
2025-06-06
Position In Range
39.68
Ppne
938,842,185
Price Date
2026-05-08
Price EBITDA
CNY 36.63
Ptbv Ratio
2.97
Relative Volume
0.65x
Revenue
2,291,761,569x
Tax By Revenue
0.22x
Tax Rate
2.21%
Tr6m
-8.11%
Volume
2,310,819
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/688139 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.0%
$0.33 annual per share
Payout ratio
+67.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+1.8%
Next ex-dividend date: 2025-06-06
Performance

SHA/688139 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+0.8%
S&P 500 1Y: n/a
3Y total return
-53.0%
S&P 500 3Y: n/a
5Y total return
-65.1%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHA/688139?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.0%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.8%
Negative means the company is buying back shares.
Technical

SHA/688139 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.3
Neutral momentum band
Price vs 200-day MA
-3.2%
50/200-day relationship not available
Beta (5Y)
0.56
Less volatile than the market
Sharpe ratio
-0.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/688139

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688139 stock rating?

sha/688139 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688139 analysis?

The full report lives at /stocks/sha/688139/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688139?

The latest report frames sha/688139 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688139 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sha/688139 stock profile: metrics, valuation and analysis | Agente de Bolsa con IA